Advanced search
Publication Cover
Journal of Medical Economics Volume 14, 2011 - Issue 2
Submit an article Journal homepage
746
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer

Josh J. Carlson University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USACorrespondence[email protected]
,
William B. Wong University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA
,
David L. Veenstra University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA
&
Carolina Reyes Genentech, Inc. South San Francisco, CA, USA
Pages 159-166 | Accepted 19 Jan 2011, Published online: 24 Mar 2011

References

  • American Cancer Society. How many people get non-small cell lung cancer? 2010 08/16 http://www.cancer.org/Cancer/LungCancer-Non-SmallCell/DetailedGuide/non-small-cell-lung-cancer-key-statistics
  • SEER. Surveillance, epidemiology, and end results (SEER) program, SEER-17 registry, public use dataset 2004-2007. 2010 12/3
  • OSI Pharmaceuticals. Tarceva package insert, 2010
  • Cappuzzo F, Ciuleanu T, Stelmakh L, et al. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study. Lancet Oncol 2010;11:6 521-9
  • United States Census Bureau. Population estimates. 2010. http://www.census.gov/
  • Ramsey SD, Martins RG, Blough DK, et al. Second-line and third-line chemotherapy for lung cancer: use and cost. Am J Manag Care 2008;14:297-306
  • NCCN. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology: non-small cell lung cancer, v.2. 2010
  • Tsimboukis S, Merikas I, Karapanagiotou EM, et al. Erlotinib-induced skin rash in patients with non-small-cell lung cancer: pathogenesis, clinical significance, and management. Clin Lung Cancer 2009;10:106-11
  • Centers for Medicare and Medicaid Services. Diagnosis related group codes. 2010. http://www.cms.gov/AcuteInpatientPPS/01_overview.asp#TopOfPage
  • Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004;22:1589-97
  • Centers for Medicare and Medicaid Services. Physician fee schedule (CY 2010). 2010
  • Analysource. Analysource online: The online resource for drug pricing and deal information. 2010. www.analysource.com
  • Ramsey SD, Clarke L, Kamath TV, et al. Evaluation of erlotinib in advanced non-small cell lung cancer: impact on the budget of a U.S. health insurance plan. J Manag Care Pharm 2006;12:472-8
  • Klein R, Wielage R, Muehlenbein C, et al. Cost-effectiveness of pemetrexed as first-line maintenance therapy for advanced nonsquamous non-small cell lung cancer. J Thorac Oncol 2010;5:1263-72
  • Okada M, Nishio W, Sakamoto T, et al. Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma. J Thorac Cardiovasc Surg 2003;126:558-62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.